U.S. Markets closed

How to Win on Stocks with a Trade War

John Blank
  • (0:20) - China’s Troubles With Tariff’s
  • (4:50) - Tariff impacts On Europe and Global Markets
  • (7:00) - Are We At The Beginning Of A Earnings Recession?
  • (8:05) - John Blanks Top Stock Picks
  • Podcast@Zacks.com

Last month we talked about the ongoing world trade situation not showing any sign of a silver lining on the horizon. We’re going to follow-up on that now with our Chief Equity Strategist and Economist, John Blank.

1. China’s economy and businesses are showing more visible signs of pain from the trade war, as recent data on producer prices and exports revealed. You were just in Beijing a few days ago. Did you see any evidence of this first hand?

2. Treasury Secretary Mnuchin reportedly had a call with his Chinese counterparts last Thursday, July 18th. He said “complicated issues” still remain in the trade war. Are these issues any different than the ones we’ve already heard about?

3. The tariff heat also includes Europe. What’s going on there?

4. What does all this mean for the overall health of the global economy and global markets?

5. Here in the U.S., the Q2 earnings season is under way. Do you think we’ll see companies exposed to tariffs take a particularly strong hit?

6. The earnings decline is expected to last through Q3. That’ll make three consecutive quarters of earnings decline. Are we looking at the beginning of an earnings recession?

7. Top Stocks on your radar include UnitedHealth Group (UNH), Lockheed Martin (LMT) and BHP Billiton (BHP), why?

That’s the story on the Global Markets with Chief Equity Strategist & Economist, John Blank. With John, I’m Terry Ruffolo.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
 
BHP Billiton Limited (BHP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research